The very word generics stiffens sinews and tightens lips in the pharma industry. It has been proposed that large profits and much pride are now being lost through the creeping forces of intellectual piracy and generic plagiarism [1-3]. In this article, I will argue against this position. Using models from evolution and modern day complexity theory I will attempt to address some of the fears that surround generic pharmaceutical enterprise and to express my own concerns about some of the overly optimistic thinking that occurs with respect to developing world systems and the HIV virus.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1517/14656566.3.9.1235 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Simultaneous extraction and purification of polysaccharides and proteins from Pleurotus ostreatus using an aqueous two-phase system.
J Food Sci
January 2025
College of Food Science and Engineering, Nanjing University of Finance and Economics/Collaborative Innovation Center for Modern Grain Circulation and Safety, Nanjing, China.
Pleurotus ostreatus is a nutrient-dense edible fungus renowned for its delicate texture, appealing flavor, and numerous potential health benefits. Simultaneous extraction within the framework of food resource processing facilitates the concurrent isolation and analysis of multiple target compounds. In this study, an ethanol/salt aqueous two-phase system (ATPS) was employed to extract polysaccharides (PS) and proteins from P.
View Article and Find Full Text PDFControlling shareholders' equity pledge and corporate innovation investment-empirical analysis based on pharmaceutical manufacturing.
Front Public Health
January 2025
School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Enterprise innovation investment is influenced by the actions of innovation subjects, whereas regulating shareholders' equity pledge behavior facilitates innovation investment and finance but also carries dangers and affects enterprise innovation investment. Methods:This paper builds an unbalanced panel model to empirically analyze the impact of controlling shareholders' equity pledges on corporate innovation and its heterogeneous characteristics. It also looks at the moderating role of corporate financing constraints and the mediating role of equity incentives, using data from A-share listed companies in China's pharmaceutical manufacturing industry from 2015 to 2022.
View Article and Find Full Text PDFRare Oncological Diseases and Their Large Slice in Demands to the Brazilian Government for Health Technologies Over 12 Years Since the Creation of CONITEC: Doenças Oncológicas Raras e Sua Grande Parcela Nas Demandas Por Tecnologias em Saúde ao Governo Brasileiro ao Longo de Doze Anos Desde a Criação da CONITEC.
Value Health Reg Issues
January 2025
Department of Pharmaceutical Sciences, Faculty of Pharmacy/Postgraduate Nursing Program, Federal University of Juiz de Fora, Minas Gerais, Brazil. Electronic address:
Objectives: To describe the characteristics of the demands for health technologies submitted to the Brazilian Government.
Methodology: A descriptive analysis was carried out by surveying the reports produced by the National Committee for the Incorporation of Health Technologies since its creation in Brazil until 2023. The extracted data were tabulated in 3 domains: identification of demand, epidemiological profile of the disease, and clinical evidence and economic assessment.
Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States.
Int J Colorectal Dis
January 2025
Exact Sciences Corporation, Madison, WI, USA.
Purpose: Colorectal cancer (CRC) is the second leading cause of cancer mortality in the USA and is highly preventable, with early screening vital for improving outcomes. This study aimed to evaluate adherence rates of multi-target stool DNA (mt-sDNA) testing, following updated guidelines recommending screening starting at age 45.
Methods: This retrospective cohort study used aggregated data from Exact Sciences Laboratories LLC, examining new users (first-time testers) aged 45-85 with commercial, Medicare, or Medicaid insurance who received mt-sDNA test kits (point-of-care) between January 1, 2023, and June 1, 2023.
Economic impact and clinical benefits of clinical pharmacy interventions: A six-year multi-center study using an innovative medication management tool.
PLoS One
January 2025
Cleopatra Hospital, Cleopatra Hospitals Group-(CHG), Cairo, Egypt.
Background: Increasing healthcare costs, particularly in Low- and Middle-Income Countries (LMICs) like Egypt, highlight the need for rational economic strategies. Clinical pharmacy interventions offer potential benefits by reducing drug therapy problems and associated costs, thereby supporting healthcare system sustainability.
Objective: This study evaluates the economic impact and clinical benefits of clinical pharmacy interventions in four tertiary hospitals in Egypt by implementing an innovative tool for medication management, focusing on cost avoidance and return on investment (ROI), while accounting for case severity and drug therapy problem (DTP) resolution.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!